SDL Desktop Products - a division of SDL International, the world’s largest provider of language translation software - announced today that Sysmex Belgium S.A., a leading provider of innovative software solutions to clinical laboratories throughout Europe, has switched to SDLX.

 “We needed a system that would be quick and easy to implement, significantly decrease our translation turnaround time, and would allow us to reuse our existing translation memories,” said Mark Montgomery, Translation Manager, Sysmex Belgium S.A.

“We switched to SDLX for a number of reasons: the cost to value ratio was much more attractive, the user interface was far more intuitive and ergonomically organized, and the quality of service, in our opinion, set a benchmark for the rest of the industry. All sales, technical and support staff were highly competent, their counsel and consultancy were without match and the quality of the training was nothing short of excellent.”

“Time to market and strict measures on quality assurance are essential to the medical software industry,” said Keith Laska, General Manager of SDL Desktop Products. “By switching to SDLX, Sysmex has reduced translation turnaround time by 50%. The unique features such as automating terminology QA checks, auto-propagation and the ability to lock specified content from translation are helping Sysmex meet the stringent quality requirements of its industry.”

With significant gains in market share in the past few years, and major investment in supporting industry standards such as TMX*, and future technologies such as XML, SDLX is quickly becoming the industry’s preferred translation memory software.


About Sysmex

Sysmex is a leading international company which designs and produces diagnostic solutions for medical laboratories world-wide. Areas of expertise include haematology, haemostasis, immunochemistry, biochemistry and urinalysis. Solutions include the provision of instruments and reagents for clinical laboratory testing, Sysmex develops a broad range of laboratory information systems and application software, thus offering information technology as part of its comprehensive service and support system. Integration of those various technologies is the driving force behind Sysmex's business activities.

Sysmex also pioneers new core technologies to address the challenges of disease prevention and early cancer detection. By expanding its business into these healthcare testing fields, Sysmex intends to contribute to the creation of a vibrant and healthy society. To find out more about Sysmex, visit www.sysmex.be.